Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.46 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.46 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 5/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL294354 | 0.98 | HTT (0.83) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL244803 | 0.95 | HTT (0.79) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Bromide SCHEMBL193632 | 0.95 | HTT (0.79) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Water SCHEMBL2150255 | 0.95 | HTT (0.79) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Fluoride Ion SCHEMBL1502817 | 0.95 | HTT (0.79) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL26106948 | 0.93 | HTT (0.76) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Iodide SCHEMBL1502813 | 0.91 | HTT (0.96) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Iodide SCHEMBL10323429 | 0.91 | HTT (0.96) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| Iodide SCHEMBL1502898 | 0.91 | HTT (0.96) | HTTSMN1; SMN2LMNAKDM4ENPC1 | |
| SCHEMBL30330430 | 0.91 | HTT (0.73) | HTTSMN1; SMN2LMNAKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115010836-A | Electrochromatic polymer, nano particles and device | 吉林大学 | 2022-09-06 | — | — | CN | claimed |
| CN-109504015-B | Electrochromic polymer material based on combination strategy and preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-108795407-B | Electrochromic material based on action of electrochromic acid and preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-108949141-B | Preparation method of bistable electrochromic material and application of bistable electrochromic material in preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-111117594-A | Electrochromic material based on dynamic metal-ligand complexation and electrochromic device | 吉林大学 | 2020-05-08 | — | — | CN | claimed |
| CN-109908960-A | A method of catalyst system and synthesizing butanol for carbon dioxide hydrogenation reaction | 中国科学院过程工程研究所 | 2019-06-21 | — | — | CN | claimed |
| CN-109504015-A | Electrochromic polymeric compounds material based on combined strategy and prepare electrochromic device | 常州铱视光电科技有限公司 | 2019-03-22 | — | — | CN | claimed |
| CN-108949141-A | The preparation method of bistable state electrochromic material and it is used to prepare electrochromic device | 常州铱视光电科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108795407-A | Based on the electroluminescent sour electrochromic material acted on and prepare electrochromic device | 常州铱视光电科技有限公司 | 2018-11-13 | — | — | CN | claimed |
| US-20160365228-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION | 2016-12-15 | — | — | US | claimed |
| US-9449797-B2 | Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface | LAM RESEARCH CORPORATION (US) | 2016-09-20 | — | — | US | claimed |
| CN-105925246-A | Electricity generated acid produced by blending substances with changeable oxidation state and electrolyte and applications thereof | 吉林大学 | 2016-09-07 | — | — | CN | claimed |
| CN-105838350-A | Electrochromic composite material and prepared electrochromic device | 吉林大学 | 2016-08-10 | — | — | CN | claimed |
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2015-11-26 | — | — | US | claimed |
| EP-2934469-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | Colgate-Palmolive Company (US) | 2015-10-28 | — | — | EP | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| CN-104143494-A | Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface | LAM RES CORP | 2014-11-12 | — | — | CN | claimed |
| WO-2014098871-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2014-06-26 | — | — | WO | claimed |
| US-12239020-B2 | Thermoelectric conversion module | LINTEC CORPORATION (JP) | 2025-02-25 | — | — | US | disclosed |
| EP-1988109-A1 | POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2008-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | MCOLN3, TAS2R39, TAS2R40 | CHRM1 1418/4885ACHE 3664/4885CHRM3 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.